Form 4: Intuitive Surgical SVP Mark Brosius Reports Stock Transactions
SEC Form 4
Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, reports the vesting and subsequent sale of restricted stock units to cover tax obligations.
Summary
- On February 29, 2024, Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, engaged in transactions involving Intuitive Surgical common stock.
- These transactions involved the vesting of restricted stock units (RSUs) and the subsequent disposition of shares to cover statutory tax withholding requirements.
- Specifically, 966 RSUs from a 2020 grant and 877 RSUs from a 2022 grant vested and converted into common stock.
- A portion of the shares obtained from the vesting of the RSUs were then sold to cover tax obligations, resulting in the disposition of 490 shares at $386.59 and 445 shares at $386.59.
- Following these transactions, Brosius directly owns 2,038 shares of Intuitive Surgical common stock and 1,754 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions related to executive compensation. It doesn't indicate positive or negative sentiment about the company's performance.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units (RSUs) that vest over time, aligning executive interests with long-term shareholder value.
- The practice of selling shares to cover tax obligations upon vesting of RSUs is standard practice among executives in publicly traded companies.
- Companies like Medtronic, Stryker, and Johnson & Johnson also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- The transactions have a minimal direct impact on shareholders, as they relate to executive compensation and tax obligations.
- The transactions provide transparency to stakeholders regarding executive stock ownership.
Key Dates
| Date | Description |
|---|---|
| 02/28/2020 | Date of restricted stock units grant that vests 25% per year over four years. |
| 02/28/2022 | Date of restricted stock units grant that vests 25% per year over four years. |
| 02/29/2024 | Date of transaction: vesting of RSUs and disposition of shares for tax obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.